BioCentury
ARTICLE | Company News

Peg-Intron approved for hepatitis C in U.S.

January 22, 2001 8:00 AM UTC

Schering-Plough (SGP) said that its Peg-Intron pegylated interferon-alpha-2b powder for injection received FDA approval as monotherapy to treat chronic hepatitis C in patients who have not been previo...